KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Imax (IMAX) Common Equity (2016 - 2025)

Imax's Common Equity history spans 16 years, with the latest figure at $349.5 million for Q3 2025.

  • For Q3 2025, Common Equity fell 4.79% year-over-year to $349.5 million; the TTM value through Sep 2025 reached $349.5 million, down 4.79%, while the annual FY2024 figure was $377.5 million, 9.45% up from the prior year.
  • Common Equity for Q3 2025 was $349.5 million at Imax, up from -$261.3 million in the prior quarter.
  • Across five years, Common Equity topped out at $419.7 million in Q3 2021 and bottomed at -$292.4 million in Q1 2023.
  • The 5-year median for Common Equity is $337.2 million (2022), against an average of $127.9 million.
  • The largest annual shift saw Common Equity soared 41395.85% in 2021 before it tumbled 7536.65% in 2023.
  • A 5-year view of Common Equity shows it stood at $410.0 million in 2021, then dropped by 8.11% to $376.7 million in 2022, then dropped by 8.44% to $344.9 million in 2023, then grew by 9.45% to $377.5 million in 2024, then fell by 7.42% to $349.5 million in 2025.
  • Per Business Quant, the three most recent readings for IMAX's Common Equity are $349.5 million (Q3 2025), -$261.3 million (Q2 2025), and -$272.4 million (Q1 2025).